Pregnancy With Multidrug-Resistant Pulmonary Tuberculosis and Autoimmune Hemolytic Anemia Complicated by Intrauterine Growth Restriction - A Case Report
Abstract
Abstract
Introduction
Intrauterine growth restriction (IUGR) is a major obstetric complication often caused by maternal infections and anemia. We present a case of IUGR in a pregnant woman caused by multidrug-resistant tuberculosis (MDR-TB) and autoimmune hemolytic anemia (AIHA).
Case presentation
A 37-year-old G5P2A2 woman with confirmed MDR-TB and AIHA was treated with levofloxacin, clofazimine, cycloserine, ethambutol, bedaquiline, and methylprednisolone. Fetal biometry showed estimated fetal weight below the 10th percentile, with a significantly declining growth curve thereafter. After administration of fetal lung maturation at 33 – 34 weeks, she underwent an elective cesarean section at 35 – 36 weeks. A female infant weighing 1,840g was delivered. The treatment for MDR-TB and AIHA in the mother was continued afterward.
Conclusion
Pregnancies complicated by MDR-TB and AIHA require strict monitoring and individualized multidisciplinary treatment. Further research is needed to establish treatment strategies that improve maternal and fetal outcomes in similar cases.
Keywords : Autoimmune hemolytic anemia; intrauterine growth restriction; multidrug resistance; pregnancy; tuberculosis.
Kehamilan dengan Tuberkulosis Paru Resisten Obat Ganda dan Anemia Hemolitik Autoimun yang Diperberat oleh Pertumbuhan Janin Terhambat – Laporan Kasus
Abstrak
Pendahuluan
IUGR adalah komplikasi obstetrik yang dapat disebabkan infeksi dan anemia pada maternal. Pada kasus ini dipresentasikan kasus wanita hamil dengan IUGR yang disebabkan multidrug resistant TB (MDR-TB) dan autoimmune hemolytic anemia (AIHA).
Ilustrasi kasus
Ibu hamil 37 tahun G5P2A2 datang dengan TB-MDR dan AIHA. Pasien menjalani terapi TB-MDR dengan levofloksasin, klofazimin, sikloserin, etambutol, dan bedaquiline, serta metilprednisolon untuk AIHA. Pada fetal biometri ditemukan estimated fetal weight (EFW) di bawah 10 persentil dengan kurva pertumbuhan janin menurun signifikan setelahnya. Setelah dilakukan induksi pematangan paru janin pada usia kehamilan 33 - 34 minggu, operasi sesar elektif dilakukan pada usia kehamilan 35 – 36 minggu melahirkan bayi perempuan dengan berat janin 1840gram. Pengobatan TB-MDR dan AIHA pada ibu dilanjutkan setelahnya.
Kesimpulan
Kehamilan dengan TB dan AIHA memerlukan pemantauan ketat dan terapi multidisiplin yang terindividualisasi. Penelitian lebih lanjut diperlukan.
Kata kunci : Hemolitik anemia autoimun; kehamilan; pertumbuhan janin terhambat; resisten obat; tuberkulosis.
Keywords
Full Text:
PDFReferences
Chew LC, Osuchukwu OO, Reed DJ, Verma RP. Fetal Growth Restriction. Treasure Island (FL); 2025.
Fleiss B, Wong F, Brownfoot F, Shearer IK, Baud O, Walker DW, et al. Knowledge Gaps and Emerging Research Areas in Intrauterine Growth Restriction-Associated Brain Injury. Front Endocrinol (Lausanne). Switzerland; 2019 Mar 29;10:188.
Garay-Aguilar N V, Reynoso-Rosales LR, Llamo-Vilcherrez AP, Toro-Huamanchumo CJ. Tuberculosis in pregnancy and adverse neonatal outcomes in two peruvian hospitals. Eur J Obstet Gynecol Reprod Biol X. Netherlands; 2024 Jun;22:100304.
Alene KA, Murray MB, van de Water BJ, Becerra MC, Atalell KA, Nicol MP, et al. Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis. JAMA Netw open. United States; 2022 Jun;5(6):e2216527.
WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Geneva; 2022.
Venkatachala RP, Sheela CN, Anandram S, Ross CR. Autoimmune Hemolytic Anaemias in Pregnancy: Experience in a Tertiary Care Hospital in South India. J Obstet Gynaecol India. 2021/03/04. India; 2021 Aug;71(4):379–85.
Cunningham F. Fetal growth disorders. Williams Obstetrics. McGraw-Hill Education; 2018.
Shrivastava D, Master A. Fetal Growth Restriction. J Obstet Gynaecol India. 2019/09/27. India; 2020 Apr;70(2):103–10.
Semchyshyn S, Cecutti A. Abdominal pregnancy complicated by genital and renal tuberculosis and hemolytic anemia. Fertil Steril. Elsevier; 1975;26(11):1142–5.
Deter RL, Lee W, Yeo L, Erez O, Ramamurthy U, Naik M, et al. Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome. Am J Obstet Gynecol. United States; 2018 Feb;218(2S):S656–78.
Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol. Elsevier; 2020 Oct 1;223(4):B2–17.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. United States; 2017 Feb;216(2):110-120.e6.
Meher S, Duley L, Hunter K, Askie L. Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 2017;216(2):121-128.e2.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. United States; 2017 Aug;377(7):613–22.
Fetal Growth Restriction: ACOG Practice Bulletin, Number 227. Obstet Gynecol. United States; 2021 Feb;137(2):e16–28.
Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet. United States; 2021 Mar;152 Suppl(Suppl 1):3–57.
Getahun D, Ananth C V, Kinzler WL. Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am J Obstet Gynecol. United States; 2007 Jun;196(6):499–507.
Fattizzo B, Bortolotti M, Fantini NN, Glenthøj A, Michel M, Napolitano M, et al. Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience. Blood. United States; 2023 Apr;141(16):2016–21
DOI: http://dx.doi.org/10.24198/obgynia.v8i3.878
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
_CROSREF22.jpg)








